IGF1 and neoplasm: Insulin, IGF1 and TNF-α have been demonstrated to negatively affect the production of sex-hormone-binding globulin (SHBG), which is the crucial carrier of testosterone and oestradiol in the plasma, thus contributing to the rise in sex steroid bioavailability and the potential increase in the risk of tumours [129,130].